TMFGBudwell

George Budwell

TMFGBudwell’s Activity

Yesterday

NL

Article

gbudwell published an article 1:39 PM

Celgene Beats on First-Quarter Earnings: What's Next?

Celgene narrowly beat consensus estimates on earnings this morning. Will biotechs shrug off the recent downturn?

NL

Article

gbudwell published an article 6:53 AM

Today's Top Health Care Stocks to Watch: AstraZeneca plc, Alexion Pharmaceuticals, Celgene Corporati

Today's top stories in biotech and health care.

Wed Apr 23

NL

Article

gbudwell published an article 8:53 AM

What We Learned from Gilead Sciences' First Quarter Earnings

Gilead Sciences crushed consensus in its first quarter earnings. Does it matter?

NL

Article

gbudwell published an article 7:52 AM

Today's Health Care Stocks to Watch: Illumina Inc., Intuitive Surgical Inc. and Gilead Sciences

Today's top stories in biotech and health care.

Tue Apr 22

NL

Article

gbudwell published an article 9:30 AM

Why Johnson & Johnson Is Outperforming the Dow

J&J has crushed the Dow Jones Industrials so far this year. Can it continue to outperform?

NL

Article

gbudwell published an article 9:13 AM

Today's Health-Care Stocks to Watch: Allergan, Inc., AstraZeneca, Pfizer, and Valeant Pharmaceutical

Today's top stories in health care and biotech.

NL

Article

gbudwell published an article 7:21 AM

Today's Health Care Stocks to Watch: Eli Lilly and Co, GlaxoSmithKline plc, Novartis AG, and Gilead

Today's top stories in biotech and health care.

Mon Apr 21

NL

Article

gbudwell published an article 10:22 AM

The FDA Gives Sarepta Therapeutics Inc. a Way Forward: Now What?

The FDA has finally agreed to a review a NDA for Sarepta's exon-skipping Duchenne muscular dystrophy drug eteplirsen. What's next?

Sun Apr 20

NL

Article

gbudwell published an article 7:57 AM

Here's What You Need to Know About Alexion Pharmaceuticals' Upcoming Earnings

Alexion Pharmaceuticals will report first-quarter earnings next Thursday. Can they beat the analysts' optimistic upward revisions?

NL

Article

gbudwell published an article 4:00 AM

3 Biotech Stocks With Upcoming Catalysts

BioDelivery Sciences International, Keryx Biopharmaceuticals, and Pozen Inc. all have near-term regulatory catalysts. Which, if any, are worth keeping tabs on?

Sat Apr 19

NL

Article

gbudwell published an article 11:55 PM

What to Watch for in Biotech Earnings This Week

Several top biotechs will report earnings this week. Will they reignite the biotech rally or drive share prices even lower?

Thu Apr 17

NL

Article

gbudwell published an article 4:23 AM

4 Reasons You Should Watch This Under-the-Radar Stock on Your Watchlist

Little known NPS Pharmaceuticals has fallen hard of late, along with other biotechs. Yet there are four compelling reasons why you should keep tabs on this stock.

NL

Article

gbudwell published an article 2:15 AM

How Are Orphan Drugmakers Faring in the Great Biotech Downturn?

Orphan drugmakers led the biotech rally upward. Is it now leading it downward?

Wed Apr 16

NL

Article

gbudwell published an article 11:38 AM

2 Reasons Why Merck & Co. Is Crushing the Dow

Merck is up double digits this year and outperforming the major indexes. Why?

NL

Article

gbudwell published an article 4:29 AM

1 of These 3 Cratering Biotechs is a Buy

Biotech stocks have been performing poorly in general this year. However, some biotechs have been having a truly terrible year. Here's a look at the three worst-performing biotechs and their respective chances at making a comeback.

Sun Apr 13

NL

Article

gbudwell published an article 10:01 PM

Why Is Regeneron Pharmaceuticals, Inc. Bucking the Downtrend?

Last week saw a widespread downturn among biotech stocks. Regeneron Pharmaceuticals, however, was able to move modestly higher. Why?

NL

Article

gbudwell published an article 7:11 AM

3 Biotech Stocks Falling Like a Knife: Puma Biotechnology, MacroGenics, and Aratana Therapeutics

Last week's three worst performing biotech stocks.

Sat Apr 12

NL

Article

gbudwell published an article 11:38 PM

Are Biotechs Bad Medicine for the S&P 500?

Are biotechs to blame for the recent downturn in the S&P 500?

Fri Apr 11

NL

Article

gbudwell published an article 8:30 AM

Today's Biotech Stocks to Watch: AbbVie Inc., Enanta Pharmaceuticals Inc. and Gilead Sciences

Today's top stories in health care and biotech.

NL

Article

gbudwell published an article 4:34 AM

3 Health Care Stocks Bucking the S&P Downtrend

Health care stocks have been falling hard of late. Have they been dragging broader indices down with them?

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 74859
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 5
Best Pick GILD (+7.59)
Worst Pick IMUC (-28.72)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to TMFGBudwell’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFGBudwell’s 10 Latest Posts